| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | A |
| 3. Samples | A |
| 4. Measurand | C |
| 5. Pre-Analytical | B |
| 6. Replicate Analysis | A |
| 7. Steady State | B |
| 8. Outlier Analysis | C |
| 9. Normality | A |
| 10. Variance Homogeneity | A |
| 11. ANOVA | B |
| 12. CI | A |
| 13. No of Results | C |
| 14. Concentrations | A |
| 15. Total Score | C4,8,13 |
| Comment | * no information about PLP |
| Parameter | Score |
|---|---|
| Matrix | Serum |
| Measurand | Aspartate transaminase (AST) |
| Unit | micromol / L |
| Overall Analytical Principle Method | Enzymatic analysis - Not specified |
| Number of Subjects | 14 |
| Number of Subjects included in BV estimation | 14 |
| Ethinicity | Caucasian |
| Age Mean / Median | 33.5 |
| Age Min | 20.0 |
| Age Max | 34.0 |
| Age SD | |
| Number of Males | |
| Number of Females | 14 |
| State of Well Being |
Healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 60 |
| Study Duration Units | Day |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | 1 |
| Interval Units | Week |
| Sampling Times | Start Time:
06:30
End Time: 08:00 |
| Number of Samples | 8 |
| Average Number of Samples Used for BV Estimation | 8.0 |
| Average Number of Replicates | 2.0 |
| Estimates of CVi | 9.74 |
| Calculated Confidence Intervals of CVi | Lower: 8.36, Upper: 11.52 |
| Estimates of CVg | |
| Calculated Confidence Intervals of CVg | Lower: 0.00, Upper: |
| Analytical CV | 5.0 |
| Calculated Confidence Intervals of Analytical CV | Lower: 4.42, Upper: 5.75 |
| Measurand Mean | 0.367 |
| Measurand Min | |
| Measurand Max | |
| Measurand SD |